(オキシム)カルバモイル脂肪酸アミド加水分解酵素インヒビター

Japanese Patent JP2005516986

A

The present invention relates to novel oxime carbamyl derivatives and pharmaceutical compositions comprising said derivatives which inhibit fatty acid amide hydrolase. These pharmaceutical compositions are useful for the treatment of conditions which can be effected by inhibiting fatty acid amide hydrolase including, but not limited to, neuropathic pain, emesis, anxiety, altering feeding behaviors, movement disorders, glaucoma, brain injury, and cardiovascular disease.

Shin-Yuen Sitt
She Kai
Den hong fen

JP2003565415A

June 09, 2005

February 04, 2003

Click for automatic bibliography generation  

BRISTOL-MYERS SQUIBB COMPANY

C07D295/08; A61K31/27; A61K31/343; A61K31/404; A61K31/4402; A61K31/4406; A61K31/4409; A61K31/443; A61K31/4439; A61K31/444; A61K31/47; A61K31/472; A61K31/5375; A61P1/08; A61P1/14; A61P3/04; A61P9/00; A61P25/02; A61P25/04; A61P25/14; A61P25/22; A61P25/28; A61P27/06; A61P29/02; A61P43/00; C07C271/26; C07C271/28; C07C271/48; C07C271/58; C07C271/60; C07D209/08; C07D209/40; C07D213/53; C07D213/64; C07D213/643; C07D213/65; C07D213/68; C07D215/20; C07D215/22; C07D217/02; C07D295/092; C07D307/91; C07D401/12; C07D405/12; (IPC1-7): C07C271/26; A61K31/27; A61K31/343; A61K31/404; A61K31/4402; A61K31/4406; A61K31/4409; A61K31/443; A61K31/4439; A61K31/444; A61K31/47; A61K31/472; A61K31/5375; A61P1/08; A61P1/14; A61P3/04; A61P9/00; A61P25/02; A61P25/04; A61P25/14; A61P25/22; A61P25/28; A61P27/06; A61P29/02; A61P43/00; C07C271/48; C07C271/58; C07C271/60; C07D209/08; C07D209/40; C07D213/53; C07D213/64; C07D213/65; C07D213/68; C07D215/20; C07D217/02; C07D295/08; C07D307/91; C07D401/12; C07D405/12

Kyousei Tamura
Toshio Ueda
Nagatoshi Shinagawa

Previous Patent: リソスタフィンを使用するブドウ球菌の鼻コロニー形成を根絶または緩和�...

Next Patent: Ｎ−置換された３−ヒドロキシ−４−ピリジノン化合物およびそれを含む�...